Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study.
Wang X, Deng Y, Zhao L, Wang L, Fu Z, Tang L, Ye F, Liu Q, Wang W, Wang S, Hu B, Guan X, Han Z, Tong Y, Rodewald LE, Yin Z, Tan W, Wang F, Huang B.
Wang X, et al. Among authors: hu b.
Vaccine. 2022 Sep 16;40(39):5701-5708. doi: 10.1016/j.vaccine.2022.08.037. Epub 2022 Aug 22.
Vaccine. 2022.
PMID: 36031501
Free PMC article.